A Medtronic medical device that industry analysts view as a potential blockbuster product has yet to gain traction in Europe, company CEO Omar Ishrak said at a conference Tuesday. Fridley-based Medtronic began selling the device, which is called Symplicity and treats high blood pressure by zapping kidney nerves, in Europe three years ago. However, many health plans there still aren't covering the product, partly because they don't understand it, Ishrak said, according to Reuters. Fridley-based…
Reported by bizjournals 16 hours ago.
↧